Cell type-specific localization of optineurin in the striatal neurons of mice: Implications for neuronal vulnerability in Huntington's disease

Neuroscience

Volumn 202, Issue , 2012, Pages 363-370

  Okita, S ^a,b   Morigaki, R ^a,b   Koizumi, H ^a,b   Kaji, R ^a,b   Nagahiro, S ^a,b   Goto, S ^a,b  

^a TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Huntingtin; Huntington's disease; Interneurons; Neurodegeneration; Optineurin; Striatum

Indexed keywords

BETA ACTIN; CYTOPLASM PROTEIN; OPTINEURIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LOSS; CELL SPECIFICITY; CELL TYPE; CELLULAR DISTRIBUTION; CLINICAL PROTOCOL; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERNEURON; MALE; MOUSE; NERVE PROJECTION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANIMALS; BLOTTING, WESTERN; CELL DEATH; CORPUS STRIATUM; DENSITOMETRY; EYE PROTEINS; GLUTAMIC ACID; HUNTINGTON DISEASE; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INTERNEURONS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; NEURONS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84856235424     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.11.059     Document Type: Article

References (49)

1. Albin R.L., Tagle D.A. Genetics and molecular biology of Huntington's disease. Trends Neurosci 1995, 18:11-14.
2. Albin R.L., Young A.B., Penney J.B., Handelin B., Balfour R., Anderson K.D., Markel D.S., Tourtellotte W.W., Reiner A. Abnormalities of striatal projection neurons and N-methyl-d-aspartate receptors in presymptomatic Huntington's disease. N Engl J Med 1990, 332:1293-1298.
3. Anborgh P.H., Godin C., Pampillo M., Dhami G.K., Dale L.B., Cregan S.P., Truant R., Ferguson S.S. Inhibition of metabotropic glutamatergic receptor signaling by the huntingtin-binding protein optineurin. J Biol Chem 2005, 280:34840-34848.
4. Bhide P.G., Day M., Sapp E., Schwarz C., Sheth A., Kim J., Young A.B., Penney J., Golden J., Aronin N., DiFiglia M. Expression of normal and mutant huntingtin in the developing brain. J Neurosci 1996, 16:5523-5535.
5. Chesselet M.F., Gonzales C., Lin C.S., Polsky K., Jin B.K. Ischemic damage in the striatum of adult gerbils: relative sparing of somatostatinergic and cholinergic interneurons contrasts with efferent neurons. Exp Neurol 1990, 110:209-218.
6. Cicchetti F., Prensa L., Wu Y., Parent A. Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease. Brain Res Brain Res Rev 2000, 34:80-101.
7. DiFiglia M., Sapp E., Chase K., Schwarz C., Meloni A., Young C., Martin E., Vonsattel J.P., Carraway R., Reeves S.A., Boyce F.M., Aronin N. Huntingtin is a cytoplasmatic protein associated with vesicles in human and rat brain neurons. Neuron 1995, 14:1075-1081.
8. Ferrante R.J., Gutekunst C.A., Persichetti F., McNeil S.M., Kowall N.W., Gusella J.F., MacDonald M.E., Beal M.F., Hersch S.M. Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. J Neurosci 1997, 17:3052-3063.
9. Ferrante R.J., Kowall N.W., Beal M.F., Martin J.B., Bird E.D., Richardson E.P. Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol 1987, 46:12-27.
10. Ferrante R.J., Kowall N.W., Beal M.F., Richardson E.P., Bird E.D., Martin J.B. Selective sparing of a class of striatal neurons in Huntington's disease. Science 1985, 230:561-563.
11. Figueredo-Cardenas G., Morello M., Sancesario G., Bernardi G., Reiner A. Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats. Brain Res 1996, 735:317-324.
12. Freiman R.N., Tjian R. Neurodegeneration: a glutamine-rich trail leads to transcription factors. Science 2002, 296:2149-2150.
13. Fusco F.R., Chen Q., Lamoreaux W.J., Figueredo-Cardenas G., Jiao Y., Coffman J.A., Surmeier D.J., Honig M.G., Carlock L.R., Reiner A. Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease. J Neurosci 1999, 19:1189-1202.
14. Goto S., Lee L.V., Munoz E.L., Tooyama I., Tamiya G., Makino S., Ando S., Dantes M.B., Yamada K., Matsumoto S., Shimazu H., Kuratsu J.I., Hirano A., Kaji R. Functional anatomy of the basal ganglia in X-linked recessive dystonia-parkinsonism. Ann Neurol 2005, 58:7-17.
15. Gourfinkel-An I., Cancel G., Trottier Y., Devys D., Tora L., Lutz Y., Imbert G., Saudou F., Stevanin G., Agid Y., Brice A., Mandel J.L., Hirsch E.C. Differential distribution of the normal and mutated forms of huntingtin in the human brain. Ann Neurol 1997, 42:712-719.
16. Gubellini P., Pisani A., Centonze D., Bernardi G., Calabresi P. Metabotropic glutamate receptors and synaptic plasticity: implications for neurological diseases. Prog Neurobiol 2004, 74:271-300.
17. Gutekunst C.A., Levey A.I., Heilman C.J., Whaley W.L., Yi H., Nash N.R., Rees H.D., Madden J.J., Hersch S.M. Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. Proc Natl Acad Sci U S A 1995, 92:8710-8714.
18. Harrington K.M., Kowall N.M. Parvalbumin immunoreactive neurons resist degeneration in Huntington's disease striatum. J Neuropathol Exp Neurol 1991, 50:309.
19. Hattula K., Peränen J. FIP-2, a coiled-coil protein, links huntingtin to Rab8 and modulates cellular morphogenesis. Curr Biol 2000, 10:1603-1606.
20. Hof P.R., Young W.G., Bloom F.E., Belichenko P.V., Celio M.R. Comparative cytoarchitectonic atlas of the C57BL/6 and 129/sv mouse brain 2000, Elsevier, Amsterdam.
21. Kosinski C.M., Cha J.H., Young A.B., Persichetti F., MacDonald M., Gusella J.F., Penney J.B., Standaert D.G. Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons. Exp Neurol 1997, 144:239-247.
22. Kowall N.W., Ferrante R.J., Martin J.B. Pattern of cell loss in Huntington's disease. Trends Neurosci 1987, 10:24-29.
23. Landwehrmeyer G.B., McNeil S.M., Dure L.S., Ge P., Aizawa H., Huang Q., Ambrose C.M., Duyao M.P., Bird E.D., Bonilla E., deYoung M., Avila-Gonzales A.J., Wexler N.S., DiFiglia M., Gusella J.F., MacDonald M.E., Penny J.B., Young A.B., Vonsattel J.P. Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals. Ann Neurol 1995, 37:218-230.
24. Langley K.C., Bergson C., Greengard P., Ouimet C.C. Co-localization of the D1 dopamine receptor in a subset of DARPP-32-containing neurons in rat caudate-putamen. Neuroscience 1997, 78:977-983.
25. Li S.H., Schilling G., Young W.S., Li X.J., Margolis R.L., Stine O.C., Wagster M.V., Abbott M.H., Franz M.L., Ranen N.G., Folstein S.E., Hedreen J.C., Ross C.A. Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 1993, 11:985-993.
26. Li Y., Kang J., Horwitz M.S. Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol Cell Biol 1998, 18:1601-1610.
27. Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., Komure O., Matsuura S., Kobatake K., Morimoto N., Abe K., Suzuki N., Aoki M., Kawata A., Hirai T., Kato T., Ogasawara K., Hirano A., Takumi T., Kusaka H., Hagiwara K., Kaji R., Kawakami H. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010, 465:223-226.
28. Moreland R.J., Dresser M.E., Rodgers J.S., Roe B.A., Conaway J.W., Conaway R.C., Hanas J.S. Identification of a transcription factor IIIA-interacting protein. Nucleic Acids Res 2000, 28:1986-1993.
29. Morigaki R., Sako W., Okita S., Kasahara J., Yokoyama H., Nagahiro S., Kaji R., Goto S. Cyclin-dependent kinase 5 with phosphorylation of tyrosine 15 residue is enriched in striatal matrix compartment in adult mice. Neuroscience 2011, 189:25-31.
30. Mrowka R., Blüthgen N., Fähling M. Seed-based systematic discovery of specific transcription factor target genes. FEBS J 2008, 275:3178-3192.
31. Nagabhushana A., Bansal M., Swarup G. Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-kB activation. PLoS One 2011, 6:e17477.
32. Park B., Ying H., Shen X., Park J.-S., Qiu Y., Shyam R., Yue B.Y. Impairment of protein trafficking upon overexpression and mutation of optineurin. PLoS One 2010, 5:e11547.
33. Pisani A., Bernardi G., Ding J., Surmeier D.J. Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci 2007, 30:545-553.
34. Reiner A., Albin R.L., Anderson K.D., D'Amato C.J., Penney J.B., Young A.B. Differential loss of striatal projection neurons in Huntington's disease. Proc Natl Acad Sci U S A 1988, 85:5733-5737.
35. Rezaie T., Child A., Hitchings R., Brice G., Miller L., Coca-Prados M., Héon E., Krupin T., Ritch R., Kreutzer D., Crick R.P., Sarfarazi M. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002, 295:1077-1079.
36. Rezaie T., Waitzman D.M., Seeman J.L., Kaufman P.L., Sarfarazi M. Molecular cloning and expression profiling of optineurin in the rhesus monkey. Invest Ophthalmol Vis Sci 2005, 46:2404-2410.
37. Sahlender D.A., Roberts R.C., Arden S.D., Spudich G., Taylor M.J., Luzio J.P., Kendrick-Jones J., Buss F. Optineurin links myosin VI to the Golgi complex and is involved in Golgi organization and exocytosis. J Cell Biol 2005, 169:285-295.
38. Sako W., Morigaki R., Kaji R., Tooyama I., Okita S., Kitazato K., Nagahiro S., Graybiel A.M., Goto S. Identification and localization of neuron-specific isoform of TAF1 in rat brain: implications for neuropathology of DYT3 dystonia. Neuroscience 2011, 189:100-107.
39. Sako W., Morigaki R., Nagahiro S., Kaji R., Goto S. Olfactory type G-protein α subunit (Gα olf) in striosome-matrix dopamine systems in adult mice. Neuroscience 2010, 170:497-502.
40. Sapp E., Schwarz C., Chase K., Bhide P.G., Young A.B., Penney J., Vonsattel J.P., Aronin N., DiFiglia M. Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol 1997, 42:604-612.
41. Sato K., Sumi-Ichinose C., Kaji R., Ikemoto K., Nomura T., Nagatsu I., Ichinose H., Ito M., Sako W., Nagahiro S., Graybiel A.M., Goto S. Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia. Proc Natl Acad Sci U S A 2008, 105:12551-12556.
42. Schilling G., Sharp A.H., Loev S.J., Wagster M.V., Li S.H., Stine O.C., Ross C.A. Expression of the Huntington's disease (IT15) protein product in HD patients. Hum Mol Genet 1995, 4:1365-1371.
43. Sharp A.H., Loev S.J., Schilling G., Li S.H., Li X.J., Bao J., Wagster M.V., Kotzuk J.A., Steiner J.P., Lo A., Hedreen J., Sisodia S., Snyder S.H., Dawson T.M., Ryugo D.D.K., Ross C.A. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 1995, 14:1065-1074.
44. Sudhakar C., Nagabhushana A., Jain N., Swarup G. NF-κB mediates tumor necrosis factor α-induced expression of optineurin, a negative regulator of NF-κB. PLoS One 2009, 4:e5114.
45. A novel gene containing a trinucleotide repeat that is expanded and unstable on HD chromosome. Cell 1993, 72:971-983. The Huntington's Disease Collaborative Research Group.
46. Trottier Y., Devys D., Imbert G., Saudou F., An I., Lutz Y., Weber C., Agid Y., Hirsch E.C., Mandel J.L. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat Genet 1995, 10:104-110.
47. Uemura Y., Kowall N.W., Beal M.F. Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum. Ann Neurol 1990, 27:620-625.
48. Vermeulen W., et al. Three unusual repair deficiencies associated with transcription factor BTF2 (TFIIH): evidence for the existence of a transcription syndrome. Cold Spring Harb Symp Quant Biol 1994, 59:317-329.
49. Zhu G., Wu C.J., Zhao Y., Ashwell J.D. Optineurin negatively regulates TNFα-induced NF-κB activation by competing with NEMO for ubiquitinated RIP. Curr Biol 2007, 17:1438-1443.